Skip to contentB
Bausch Health Companies Inc.
B
BHCBausch Health Companies Inc. Q4 2020 · 10-K
Revenue$2.21B$2.21B−0.5% vs Q4 2019 Net Income-$153.00M-$153.00MderivedN/M vs Q4 2019 EPS Diluted-$0.43-$0.43N/M vs Q4 2019 Operating Income-$5,000,000
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bausch Health Companies Inc. · CIK 885590 · Engraved from SEC EDGAR
N/M
Operating Cash Flow$394,000,000+68.4% Free Cash Flowderived$314,000,000+101.3% Margins · derivedOperating margin-0.2%+48.2 pt vs Q4 2019
Net margin-6.9%+61.5 pt vs Q4 2019
ended Dec 31, 2020 · filed Feb 24, 2021 · 55 d after period end